Our investment case HIGH-QUALITY GLOBAL MANUFACTURING FOOTPRINT AND EFFICIENT OPERATIONS Hikma has an extensive and well-established manufacturing footprint.
We operate 29 facilities in 11 countries, across the US, Europe and the MENA, 12 of which are approved by the US FDA and nine of which are EU-approved.
The strategic investment we have made in our manufacturing capabilities and capacity has created a strong competitive advantage and enabled us to capture significant market opportunities.
Quality is critical to our success and our excellent track record of regulatory compliance has made us a trusted partner to our customers.
Number of production employees 4,904 4,904 3,986 3,896 14 15 16 Hikma Pharmaceuticals PLC 12 Strategic report Corporate governance Financial statements Annual Report 2016 13
